A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

NCT00158093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Nebivolol
DRUG: Atenolol
DRUG: Moxifloxacin

Sponsor

Mylan Bertek Pharmaceuticals